Novel Nanoparticulate Systems for Idiopathic Pulmonary Fibrosis: A Review

    November 2020 in “ Asian Journal of Pharmaceutical and Clinical Research ”
    Kiran Dudhat, Harsha V. Patel
    Studysummary This review discusses the potential of nanotechnology in treating idiopathic pulmonary fibrosis by targeting abnormal alveolar epithelial cells and reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on innovareacademics.in →
    Discuss this study in the Community →